A Randomized, Multicenter, Open-Label Comparison of the Antiemetic Efficacy of Dolasetron Versus Ondansetron for the Prevention of Nausea and Vomiting During High-Dose Myeloablative Chemotherapy
- Resource Type
- Article
- Source
- In
Supportive Cancer Therapy January 2005 2(2):114-121 - Subject
Original Contributions - Language
- ISSN
- 1543-2912